Tetraethylenepentamine-Coated β Cyclodextrin Nanoparticles for Dual DNA and siRNA Delivery.
Chi-Hsien LiuPei-Yin ShihCheng-Han LinYi-Jun ChenWei-Chi WuChun-Chao WangPublished in: Pharmaceutics (2022)
Nucleic acid reagents, including plasmid-encoded genes and small interfering RNA (siRNA), are promising tools for validating gene function and for the development of therapeutic agents. Native β-cyclodextrins (BCDs) have limited efficiency in gene delivery due to their instable complexes with nucleic acid. We hypothesized that cationic BCD nanoparticles could be an efficient carrier for both DNA and siRNA. Tetraethylenepentamine-coated β-cyclodextrin (TEPA-BCD) nanoparticles were synthesized, characterized, and evaluated for targeted cell delivery of plasmid DNA and siRNA. The cationic TEPA coating provided ideal zeta potential and effective nucleic acid binding ability. When transfecting plasmid encoding green fluorescent protein (GFP) by TEPA-BCD, excellent GFP expression could be achieved in multiple cell lines. In addition, siRNA transfected by TEPA-BCD suppressed target GFP gene expression. We showed that TEPA-BCD internalization was mediated by energy-dependent endocytosis via both clathrin-dependent and caveolin-dependent endocytic pathways. TEPA-BCD nanoparticles provide an effective means of nucleic acid delivery and can act as potential carriers in future pharmaceutical application.
Keyphrases
- nucleic acid
- cancer therapy
- gene expression
- escherichia coli
- crispr cas
- genome wide
- hyaluronic acid
- drug delivery
- dna methylation
- poor prognosis
- binding protein
- capillary electrophoresis
- copy number
- single cell
- ionic liquid
- mass spectrometry
- small molecule
- human health
- stem cells
- mesenchymal stem cells
- protein protein
- risk assessment
- cell free
- long non coding rna